Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion type Assertion NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_head.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion wasGeneratedBy ECO_0000203 NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion wasDerivedFrom befree-20150227 NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion SIO_000772 16300471 NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion evidence source_evidence_literature NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.
- NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764750.RA1hxRmezfK0Zuedzla0z2XverOdSEV3-ugKJG61LFOxA130_provenance.